Get started
Author

Hela Romdhani

Observed names: H Romdhani, H. Romdhani, Romdhani, Hela
ORCID: 0000-0001-5219-2612
Observed ORCID: 0000-0001-5219-2612
OpenAlex ID: A5083172350
Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data
2021 · Stephen J. Freedland, Xuehua Ke, et al. · Current Medical Research and Opinion · 37
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews
2022 · Babafemi O. Taiwo, Hela Romdhani, et al. · Journal of Drug Assessment · 36
Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy
2019 · Bruno Emond, Murali Sundaram, et al. · Clinical Lymphoma Myeloma & Leukemia · 30
Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
2018 · Bruno Emond, Kruti Joshi, et al. · PharmacoEconomics - Open · 17
PDF
Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV
2018 · Keith Dunn, Marie-Hélène Lafeuille, et al. · Journal of Managed Care & Specialty Pharmacy · 16
PDF
Current Treatment Patterns Among Postmenopausal Women with HR+/HER2− Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study
2018 · Deborah Goldschmidt, Anand A. Dalal, et al. · Advances in Therapy · 14
Treatment patterns in men with metastatic castration sensitive prostate cancer (mCSPC) in the United States (US).
2020 · Xuehua Ke, Marie-Hélène Lafeuille, et al. · Journal of Clinical Oncology · 11
Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfp
2023 · Jay Portnoy, Jodi Shroba, et al. · Annals of Allergy Asthma & Immunology · 9
PDF
Disease Management and Outcomes in Patients Hospitalized for Acute Heart Failure in Japan
2021 · Lei Chen, Raluca Ionescu-Ittu, et al. · Cardiology and Therapy · 8
PDF
Economic burden of treatment failure in chronic lymphocytic leukemia patients
2018 · Song Wang, Marie-Hélène Lafeuille, et al. · Current Medical Research and Opinion · 7
Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus
2019 · Carmela Benson, Bruno Emond, et al. · Journal of Managed Care & Specialty Pharmacy · 6
PDF
Real-World Utilization and Safety of Daratumumab IV Rapid Infusions Administered in a Community Setting: A Retrospective Observational Study
2021 · Lucio Gordan, Melody Chang, et al. · Drugs - Real World Outcomes · 5
PDF
Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US
2025 · Jason Hafron, Agnes Hong, et al. · Future Oncology · 4
Treatment Patterns and Modifications of Tyrosine Kinase Inhibitors (TKI) Therapy in Early Lines in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Real-World Analysis from a Large Commercial Claims Database in the United States (US)
2023 · Vamsi K. Kota, David Wei, et al. · Blood · 4
Global Assessment of Health Utilities Associated with Pneumococcal Disease in Children—Targeted Literature Reviews
2025 · Min Huang, Jipan Xie, et al. · PharmacoEconomics · 3
PDF
EPS6.05 Clinical outcomes in concurrent elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) treated vs. ineligible cohorts in the US Cystic Fibrosis Foundation Patient Registry (CFFPR) during COVID-19
2024 · C. Merlo, H. Romdhani, et al. · Journal of Cystic Fibrosis · 3
Real-world clinical outcomes and healthcare costs in patients with Crohn’s disease treated with vedolizumab versus ustekinumab in the United States
2024 · Michael Chiorean, Jeanne Jiang, et al. · Current Medical Research and Opinion · 3
Real-World Utilization and Safety of Daratumumab Rapid Infusion Administered in a Community Setting: A Retrospective Observational Study
2019 · Lucio Gordon, Melody Chang, et al. · Blood · 3
Real-World Effectiveness and Safety of Deutetrabenazine in Combination with Antipsychotic Drugs in Patients With Chorea Associated With Huntington Disease (P2-11.010)
2023 · Daniel Claassen, Hela Romdhani, et al. · Neurology · 2
P114 Physician Experience With Prescribing Peanut (arachis Hypogaea) Allergen Powder-dnfp in Pediatric Patients With Peanut Allergy
2021 · J. Portnoy, J. Shroba, et al. · Annals of Allergy Asthma & Immunology · 2
Healthcare resource use (HRU) in men with metastatic castration sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT) only or no treatment in the United States (US).
2020 · Xuehua Ke, Marie-Hélène Lafeuille, et al. · Journal of Clinical Oncology · 2
Abstract P6-18-38: Treatment patterns and sequences among pre-menopausal women with HR+/HER2- metastatic breast cancer: A chart review study
2019 · AA Dalal, D Goldschmidt, et al. · Cancer Research · 2
Non-optimal treatment with first tyrosine kinase inhibitor and associated economic burden in chronic myeloid leukemia
2025 · Vamsi Kota, David Wei, et al. · Journal of Medical Economics · 1
PDF
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis
2024 · Michael Ingham, Hela Romdhani, et al. · Journal of Market Access & Health Policy · 1
PDF
Evaluation of persistence and adherence for oral and injectable androgen deprivation therapies (ADT) in United States (US) patients with prostate cancer (PC).
2024 · Jason Hafron, Agnes Hong, et al. · Journal of Clinical Oncology · 1
PDF
Works count: 60
Citation count: 230
H-index: 8
I10-index: 7
Year
Topic
Type